A MD Anderson Expert's Remote Second Opinion - a Collaborative Case Study with a Hospital in Asia
- Medebound HEALTH

- Jul 6, 2025
- 7 min read
Updated: Feb 2
Author: Medical Editor Iris
Content
A Global Online Second Opinion Collaboration for a Cancer Patient in Asia
For patients trying to obtain a second opinion from MD Anderson and aren’t sure how to access one remotely, this case illustrates one alternative pathway — and its limitations.
In this notable international case, a top senior doctor with professional appointment at MD Anderson Cancer Center in the U.S. and a leading surgeon from Peking Union Medical College Hospital (PUMCH, ranked #1 in China) worked together. They developed a potential curative treatment plan for a patient with a recurring yolk sac tumor.
Medebound HEALTH facilitated this cross-border video consultation/ second opinion, handled complex logistics, and delivered compassionate and professional services for the patient and her family.
Note: All consultations are provided by independent U.S.-licensed physicians and are not services of any hospital or cancer center as an institution.
Patient Overview
Patient: Ms. Lin (alias), 33 years old
Primary Concern: Seeking a second opinion from MD Anderson
Local Hospital: Peking Union Medical College Hospital (PUMCH), Beijing
Diagnosis: Recurrent yolk sac tumor post-surgery
US Expert: Rare ovarian cancer specialist currently appointed at MD Anderson
Proposed Second Opinion Plan: High-dose chemotherapy + autologous stem transplantation
Curative Rate: Estimated 30%–50%, potentially higher
Patient Outcome: Highly satisfied; considering overseas treatment
Understanding Yolk Sac Tumors
Yolk sac tumors are rare ovarian germ cell tumors usually found in younger women aged 10–30. Though the exact cause is unknown, factors such as genetic mutations, chromosomal abnormalities, and syndromes like Swyer syndrome may play a role. Due to their rarity and aggressive nature, treatment often requires specialized, high-dose regimens unavailable in most countries.
The Journey: From Asia to a U.S. Second Opinion via Medebound HEALTH
Ms. Lin (alias to protect patient's privacy) had already undergone three surgeries and six rounds of chemotherapy, only to face another recurrence of her tumor. Treated initially by Professor Yang (alias), a highly respected ovarian cancer surgeon at PUMCH, her options were becoming limited.
Recalling a rare tumor expert he met during a U.S. fellowship, Prof. Yang encouraged Ms. Lin to seek a second opinion from MD Anderson. After unsuccessful direct contact, Ms. Lin’s family turned to Medebound HEALTH.
Founded in 1941 and located in Houston, Texas, MD Anderson is a globally leading comprehensive cancer center, ranked No. 1 in the U.S. for cancer care multiple times. It was among the first cancer centers designated by the U.S. government under the 1971 National Cancer Act.

Understanding Cancer Second Opinions at MD Anderson
For many patients navigating a challenging cancer diagnosis, the idea of a second opinion from a world-renowned institution like MD Anderson Cancer Center represents the gold standard of reassurance. MD Anderson is consistently ranked among the top cancer centers in the United States and is known for its multidisciplinary expertise, advanced research programs, and highly experienced specialists across virtually all tumor types.
However, it is important to clearly understand what MD Anderson’s official second-opinion pathway entails. At present, the center typically provides second opinions in the context of in-person new-patient evaluations rather than as a standalone remote or virtual service. In other words, patients generally must travel to Houston, undergo a standard new-patient workup, and meet with oncology specialists directly to receive a formal institutional opinion.
This in-person model allows clinicians to review imaging, pathology, and clinical history in a comprehensive clinical context, including repeat testing when necessary. It also enables direct physical examination and integration with MD Anderson’s multidisciplinary teams, which may be essential for planning complex treatment strategies.
However, the practical realities of international travel, time commitment, and expense can make this approach difficult for many patients — especially early in the decision-making process.
The Medebound HEALTH Solution: Fast, Accurate, Global
Upon receiving Ms. Lin’s request, Medebound HEALTH international medical team swiftly reviewed her history, secured her preferred MD Anderson-affiliated expert, and even offered an alternative from Memorial Sloan Kettering Cancer Center. Within just one week, a cross-border video consultation was arranged.
Consultation Highlights
Date: May 16, 2023, 8:00 PM EST
Location: Virtual meeting room with PUMCH’s Prof. Yang and team present
Language & Records: All records translated and 5 key questions prepared by Medebound HEALTH
Additional Scans: U.S. expert requested PET/CT from a top-tier Chinese hospital
A key highlight was the clinical discussion between Prof. Yang and the MD Anderson-affiliated expert:
Consideration of surgical removal of hypermetabolic nodules
Consensus: Surgery not recommended due to prior radiation and location
Expert Second Opinion
After detailed review, the MD Anderson-affiliated specialist ruled out targeted and immunotherapies due to lack of actionable mutations. Instead, he proposed a bold, potentially curative regimen:
High-dose chemotherapy with etoposide and carboplatin
Followed by autologous originated stem cell transplantation
This therapy is only available in specialized U.S. centers, offering 30%–50% cure rates, higher in some cases.
Post-Consultation: Report & Response
Two days later, Medebound HEALTH delivered a bilingual written report summarizing all expert opinions and recommendations.
Patient feedback:
"Professional, warm, efficient, more than what we hoped for. We are excited about the curative possibility that we have never learned locally!"
Recognized by Forbes, Medebound HEALTH has been trusted by Fortune 500 and used by thousands of affluent families worldwide. Learn More Here.
Why Remote Expert Perspective Matters (Before or Instead of Travel)
For patients who are considering an institutional consultation but are unable to travel immediately, are uncertain whether travel is necessary, or simply want more detailed insight into their diagnosis and options before committing to a major trip, an independent expert review can play a valuable role.
In contrast to formal institutional second opinions, an independent remote review hinges on the knowledge and experience of individual U.S.-licensed cancer specialists. These physicians may have trained, held academic appointments, or maintained clinical affiliations with top centers — including MD Anderson and other leading institutions — but the opinion they offer is provided in their professional capacity outside of the hospital’s official care pathways.
Such remote consultations are based entirely on medical records — including pathology, imaging, and treatment history — and aim to provide clarity around diagnosis, staging, and evidence-based treatment strategies. They do not establish a physician-patient relationship with any hospital as an entity, nor do they substitute for direct clinical care or in-person examinations.
Medebound HEALTH - Our integrative approach
To illustrate how remote expert review can help clarify complex clinical decisions, we shared a collaborative case involving a rare recurrent ovarian germ cell tumor.
What the Service Includes
Expert Matching: Cases are matched to U.S.-licensed oncologists who have advanced training or appointments at top cancer centers, including MD Anderson when clinically appropriate.
Medical Record Preparation: The medical team assists in organizing and, if needed, translating pathology, imaging, and clinical documentation.
Written Second Opinion Report: A structured report outlines diagnosis confirmation, evidence-based treatment recommendations, and interpretations of key tests.
Optional Video Consultation: Patients may discuss findings directly with the reviewing specialist.
Clinical Trial and Strategy Guidance: Where relevant, the opinion may include information on trial eligibility or emerging therapies.
This approach helps patients gain expert perspective in a medically structured format that supports subsequent decisions, whether pursued locally or through institutional care.
Important Considerations:
Insurance Coverage: Check with your insurance provider regarding coverage for second opinion consultations, as many may not cover the cost.
Second Opinion Limitation: U.S. second opinion consultations are for reference purposes only. The physician-patient relationship is not formed with your remote physician. Remote consultations differ from in-person visits and are subject to limitations due to lack of direct in-person examination. As such you will need to understand Medebound HEALTH and the U.S. doctor are not liable for any treatment decisions made based on the second opinion, and accept the risks of relying on any information provided under this agreement. You will need to sign an agreement to confirm that you voluntarily request this service and understand its limitations.
Timeliness: Getting a second opinion early in your treatment journey, ideally before starting treatment, can be beneficial.
Frequently Asked Questions (FAQs) About MD Anderson
Can I get an online second opinion for cancer from doctors at Top Centers without traveling?
Yes. We offer a secure remote cancer consultation service that allows international patients to receive expert oncology advice without visiting the U.S. Top Centers in person.
What is included in a second opinion through Medebound HEALTH?
Patients receive a thorough review of their existing diagnosis and treatment plan by a leading cancer hospitals like MD Anderson cancer specialist. This may include a written report, molecular or pathology review, and recommendations for advanced therapies or clinical trials.
How do international patients request a second opinion from experts at top U.S. cancer centers such as MD Anderson?
Through Medebound HEALTH, patients can submit their medical records online, make payment securely, and receive guidance throughout the process including translation services if needed.
What types of cancer can be reviewed remotely?
We provide virtual second opinions for nearly all major cancers, including breast, lung, liver, pancreatic, prostate and rare tumors.
How long does it take to receive a remote second opinion for cancer?
Once medical records are complete, patients typically receive their online second opinion from MD Anderson within 7 business days.
How to Apply
You are looking for clarity, confidence, and expert insight from world-class cancer doctors without the pain of international travel.
Medebound HEALTH is designed to provide precisely that:
Access to U.S. expert insights,
Fast turnaround so treatment decisions aren’t delayed,
Support through coordination, translation, and expert matching.
Email: support@medeboundhealth.com
Website: www.medeboundhealth.com
WhatsApp: click HERE Submit the form: Click HERE we will get back within 4 hours Instant Chat: Click the chat button at the lower right corner of this page👇
About Medebound HEALTH: Since 2016, we've helped thousands of affluent families mostly from Asia get personalized cancer remote second opinions from the top 1% of US hospitals through simple written opinion or video calls. These are the same top doctors trained or active at top hospitals such as MD Anderson, Mayo Clinic, Memorial Sloan Kettering and Johns Hopkins, etc, you will get their expertise, their treatment suggestion, and their guidance - all from your home. No matter where you live, world-class cancer care is just a few steps away.

Disclaimer
We strive to maintain the accuracy and provide regular updates for the treatment information described in this article. However, treatment outcomes may vary between individuals. The information provided here is not intended as a diagnostic or treatment recommendation and should not replace the careful evaluation and advice of your attending physician. The service is independently operated by Medebound HEALTH and is not provided, partnered, or affiliated with any hospital center as an institution.










Comments